Boule Diagnostics AB 2021 IR
The report outlines Boule Diagnostics AB's financial, operational, and sustainability performance for the fiscal year 2021. Despite pandemic-related challenges, the company achieved record sales of SEK 463 million, driven by a recovery in demand for instruments and consumables. Key milestones included the launch of a local reagent production facility in Russia, expansion in the Middle East and Africa, and the growth of the Boule Academy training platform. In sustainability, Boule focused on product safety, quality assurance, and reducing transportation emissions, while aligning its operations with UN Sustainable Development Goals 3 and 9.
Company: Boule Diagnostics AB
Sector: Health Care
Country: Sweden
Year: 2021
Type: IR
Pages: 92
Back to company
Boule Diagnostics AB
Annual And Sustainability Report
The report outlines Boule Diagnostics AB's financial, operational, and sustainability performance for the fiscal year 2021. Despite pandemic-related challenges, the company achieved record sales of SEK 463 million, driven by a recovery in demand for instruments and consumables. Key milestones included the launch of a local reagent production facility in Russia, expansion in the Middle East and Africa, and the growth of the Boule Academy training platform. In sustainability, Boule focused on product safety, quality assurance, and reducing transportation emissions, while aligning its operations with UN Sustainable Development Goals 3 and 9.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees